Genetic and Social Network Correlates of Rheumatoid Arthritis Outcomes in Hispanic Populations: A Prospective Study
2 other identifiers
observational
28
1 country
2
Brief Summary
Background: Rheumatoid arthritis (RA) is more severe in Hispanic people. Genetics plays a role. But social issues may also lead to more severe RA in Hispanics. Some Hispanics may not seek help for early symptoms. Support from family and friends may persuade people to seek treatment earlier. Researchers want to learn more about how social factors affect RA in Hispanics. Objective: This natural history study will explore genetic and social factors related to RA in Hispanic families. Eligibility: People aged 18 years or older of Hispanic/Latino heritage. They may have RA or RA symptoms; they may also have a relative or partner with RA or RA symptoms. Design: Participants will receive an email or text with a link to a 30-minute online survey. They will answer questions about these things: Physical and emotional health How health problems affect their life Family history of RA and other conditions Cultural identity and language preference Participants may also answer these questions in a phone call or an in-person interview. Participants will be asked to list people in their social network. They will answer questions about those relationships. They will be asked if they want to invite their family and friends to participate in the study. If more than 1 person from a participant s family takes part in the study, they may be invited for an interview. They will answer questions about how arthritis pain affects their mind and body. Participants will give a sample of saliva. They will spit into a vial. They will mail it in using a prepaid label.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2022
CompletedFirst Posted
Study publicly available on registry
July 14, 2022
CompletedStudy Start
First participant enrolled
November 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2024
CompletedJanuary 19, 2024
January 1, 2024
1.1 years
July 9, 2022
January 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Family networks
Evaluate the associations between family networks, RA-related health communication and use of health service, and RA severity across levels of genetic susceptibility
One time
Study Arms (2)
family members
family members of those with rheumatoid arthritis
rheumatoid arthritis
persons with rheumatoid arthritis
Eligibility Criteria
Adult participants of Hispanic origin experiencing rheumatoid arthritis (RA) symptoms and their family members
You may qualify if:
- Consistent with the study objective, to be eligible to participate in this study, an individual must meet all of the following:
- Age 18 and over;
- Able to speak either English or Spanish;
- Of Hispanic/Latino heritage (regardless of country of origin);
- Meeting one of the following: (a) has RA or RA symptoms, (b) has at least one biological kin who has RA or RA symptoms, (c) has a spouse/partner who has RA or RA symptoms. It is not required to have an official diagnosis or records of symptoms. The screening questionnaire will screen prospective participants for either a confirmed diagnosis of RA or presence of inflammatory polyarthritis (pain, swelling and stiffness in three or more joints), which is the evaluation criterion for suspected RA in absence of laboratory testing, for themselves or their biological relatives or spouse/partner;
- Able and willing to give written informed consent.
You may not qualify if:
- This is a study being conducted at NHGRI s intramural research program. Therefore, NHGRI staff will be excluded from as a safeguard against the risk of ethical concerns.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, 20892, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jielu Lin, Ph.D.
National Human Genome Research Institute (NHGRI)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2022
First Posted
July 14, 2022
Study Start
November 21, 2022
Primary Completion
January 9, 2024
Study Completion
January 9, 2024
Last Updated
January 19, 2024
Record last verified: 2024-01